Professional Seasonal Analysis for Trading

Viridian Therapeutics, Inc. - Common Stock (VRDN)

Seasonality Analysis

Stocks 12 Years Analyzed

Viridian Therapeutics, Inc. - Common Stock Annual Seasonality Statistics

-2.38%
Avg Annual Return
39.1%
Avg Monthly Win Rate
5/12
Positive Months
12
Years Analyzed

Viridian Therapeutics, Inc. - Common Stock Monthly Seasonality Performance

Month Avg Return Win Rate Strength
January BEST 23.83%
50%
Weak
February -8.97%
17%
Very Weak
March WORST -10.53%
25%
Very Weak
April 2.07%
67%
Strong
May 0.13%
36%
Weak
June -1.37%
50%
Weak
July 0.71%
42%
Weak
August -7.93%
17%
Very Weak
September -0.97%
42%
Weak
October -3.74%
25%
Very Weak
November 10.29%
67%
Strong
December -5.90%
33%
Very Weak

Viridian Therapeutics, Inc. - Common Stock 2026 vs Historical Pattern

Current Position
4.93
Historical Avg Position
40.29
Deviation
-35.36
Performance
Significantly Below Average

Viridian Therapeutics, Inc. - Common Stock Interactive Seasonality Chart

Interactive Seasonality Chart

Unlock the full interactive seasonality chart for VRDN with overlay patterns, custom date ranges, and more.

Create Free Account

Viridian Therapeutics, Inc. - Common Stock Pattern Scanner

Pattern Scanner

Discover recurring patterns, anomalies, and statistically frequent setups.

Create Free Account

Viridian Therapeutics, Inc. - Common Stock Seasonal Historical Performance

Historical Performance

See historical average returns for VRDN across multiple timeframes.

Create Free Account

About Viridian Therapeutics, Inc. - Common Stock (VRDN) Seasonality

Viridian Therapeutics, Inc. - Common Stock (VRDN) has been analyzed using 12 years of historical data to identify seasonal patterns. Classified under Stocks, Viridian Therapeutics, Inc. - Common Stock shows distinct seasonal tendencies based on historical data.

The strongest month for Viridian Therapeutics, Inc. - Common Stock is historically January, with an average return of 23.83% and a win rate of 50%. Conversely, March tends to be the weakest month, averaging -10.53% return.

Looking at the full calendar year, Viridian Therapeutics, Inc. - Common Stock has an average annual return of -2.38% with an overall monthly win rate of 39.1%. Out of 12 months, 5 typically show positive average returns.

The seasonal pattern for Viridian Therapeutics, Inc. - Common Stock has a consistency score of 52.7 (Fair), based on 13 years of data. Higher consistency means the seasonal pattern has been more reliable across different market conditions.

Viridian Therapeutics, Inc. - Common Stock Seasonality FAQ

What is the best month to buy Viridian Therapeutics, Inc. - Common Stock (VRDN)?

Historically, January has been the best month for Viridian Therapeutics, Inc. - Common Stock, with an average return of 23.83% and a win rate of 50%. However, past performance does not guarantee future results.

What is the worst month for Viridian Therapeutics, Inc. - Common Stock (VRDN)?

Based on historical data, March has been the weakest month for Viridian Therapeutics, Inc. - Common Stock, with an average return of -10.53%. This is a historical observation and does not guarantee future results.

How reliable is VRDN seasonality data?

The seasonality analysis for Viridian Therapeutics, Inc. - Common Stock is based on 12 years of historical price data. While seasonal patterns can provide useful insights, they should be combined with other forms of analysis. Past patterns do not guarantee future performance.

How can I use Viridian Therapeutics, Inc. - Common Stock seasonality in my trading?

Use Viridian Therapeutics, Inc. - Common Stock (VRDN) seasonality as one factor in your analysis. Identify historically strong and weak months, combine with other research methods. SeasOptima provides premium tools including interactive charts, pattern scanning, and historical performance data for deeper analysis.

More Stocks Seasonality Analysis

Statistical information based on historical data. Does not constitute investment advice or recommendation. Past performance does not guarantee future results.